Oscar Health, INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NYSE
William Gassen, a Director of Oscar Health, Inc., received 684 shares of common stock on July 9, 2026.
NYSE
Sid Sankaran, a Director of Oscar Health, Inc., received 858 shares of common stock on July 9, 2026.
NYSE
David Plouffe, a Director of Oscar Health, Inc., received 681 shares of common stock on July 9, 2026.
NYSE
Oscar Health Director Mario Schlosser executed a Rule 10b5-1 trading plan, resulting in the sale of a significant number of Class A common stock shares.
NYSE
Oscar Health CEO Mark Bertolini sold a significant number of Class A common stock shares to cover tax obligations related to vested performance stock units, executing a pre-planned Rule 10b5-1 transaction.
NYSE
Oscar Health CEO Mark Bertolini sold company stock to cover tax obligations related to vested stock units, executing a pre-planned Rule 10b5-1 trading plan.
NYSE
Oscar Health Director Mario Schlosser executed a series of transactions involving Class A common stock, including acquisitions and dispositions, on June 23, 2026, under a Rule 10b5-1 trading plan.
NYSE
Oscar Health, Inc. reports a Form 4 filing detailing a transaction by Director Laura W. Lang, acquiring 8,475 shares of Class A Common Stock.
NYSE
Oscar Health Director David Plouffe acquired 8,475 shares of Class A Common Stock through restricted stock units.
NYSE
Oscar Health, Inc. Director Sankaran Sid reported transactions involving Class A Common Stock and Restricted Stock Units.
NYSE
Oscar Health Director William Gassen acquired 8,475 restricted stock units on June 4, 2026, as detailed in a Form 4 filing.
NYSE
Oscar Health, Inc. reports that Director Vanessa Ames acquired 8,475 restricted stock units on June 4, 2026.
NYSE
Oscar Health's Chief Accounting Officer, Victoria Baltrus, sold shares to cover tax obligations from vested equity awards.
NYSE
Oscar Health Director Mario Schlosser sold 34,120 shares of Class A Common Stock to cover tax obligations from equity award vesting.
NYSE
Oscar Health's Chief Legal Officer, Adam McAnaney, sold shares of Class A Common Stock to cover tax withholding obligations from vested equity awards.
NYSE
Oscar Health's President of Oscar Insurance, Janet Liang, has sold a significant number of Class A common stock shares.
NYSE
Oscar Health's Chief Financial Officer, Richard Scott Blackley, has sold a significant number of Class A Common Stock shares as part of a pre-arranged trading plan.
NYSE
Oscar Health's Chief Financial Officer, Richard Scott Blackley, has sold a significant number of Class A common stock shares as part of a pre-arranged trading plan.
NYSE
Oscar Health, Inc. reports that Director Sankaran Sid received 1,203 deferred stock units on April 9, 2026, as part of a compensation plan.
NYSE
William Gassen, a Director at Oscar Health, Inc., has elected to receive deferred stock units in lieu of cash retainer payments, reflecting a strategic alignment with the company's stock performance.
NYSE
Oscar Health director Jeffery H. Boyd has received 3,610 deferred stock units, settled in Class A common stock, as part of his compensation for board service.
NYSE
Oscar Health director David Plouffe received 1,461 deferred stock units on April 9, 2026, as part of a compensation plan.
NYSE
Oscar Health CEO Mark T. Bertolini reported transactions involving Class A Common Stock and Performance Restricted Stock Units.
NYSE
Oscar Health's Chief Financial Officer, Richard Scott Blackley, gifted 75,000 shares of Class A Common Stock to an irrevocable family trust.
NYSE
Oscar Health President Janet Liang reported the acquisition of restricted stock units and the sale of shares to cover tax obligations.
NYSE
Oscar Health's CEO, Mark T. Bertolini, was granted 1,596,877 restricted stock units vesting over three years starting March 2027.
NYSE
Oscar Health's Chief Accounting Officer, Victoria Baltrus, acquired restricted stock units and sold a portion of shares to cover tax obligations.
NYSE
Oscar Health's Chief Legal Officer, Adam McAnaney, reported the acquisition of restricted stock units and the sale of shares to cover tax withholding obligations.
NYSE
Oscar Health's President of Technology & CTO, Mario Schlosser, acquired restricted stock units and sold shares to cover tax obligations.
NYSE
Oscar Health's CFO, Richard Scott Blackley, reported the acquisition of restricted stock units and a pre-planned sale of shares to cover tax obligations.